Investors NYSE AMERICAN: LCTX Minimum 15 minutes delayed. Source: LSEG VIEW STOCK QUOTE Press Releases November 05, 2026 Lineage Cell Therapeutics to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026 October 29, 2026 Lineage Provides Update on ReSonance® Program for Hearing Loss September 08, 2026 Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform VIEW PRESS RELEASES Events & Presentations Lineage Cell Therapeutics Corporate Overview (September 14, 2026) 4.7 MB OpRegen® 3 Year Clinical Data Update (Retinal Innovation Summit 2026) 2.1 MB Roche Pharma Day 2025 Presentation 8.1 MB Third Quarter 2026 Financial Results Earnings Call Nov 12, 2026 at 4:30 PM EST Click here for webcast VIEW EVENTS & PRESENTATIONS
November 05, 2026 Lineage Cell Therapeutics to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026
September 08, 2026 Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform
Third Quarter 2026 Financial Results Earnings Call Nov 12, 2026 at 4:30 PM EST Click here for webcast
